Upregulation of Nrf2/HO-1 signaling and farnesoid X receptor and attenuation of oxidative stress and inflammation mediate the protective effect of sitagliptin against diabetic nephropathy in rats

Hasan, IH, Alqahtani, QH, Sarawi, WS, ALMatrafi, TA, Al-Saab, J, Hassanein, EHM, Ahmed, NA, El Mohtadi, M, Anany, M and Mahmoud, AM ORCID: https://orcid.org/0000-0003-0279-6500 (2025) Upregulation of Nrf2/HO-1 signaling and farnesoid X receptor and attenuation of oxidative stress and inflammation mediate the protective effect of sitagliptin against diabetic nephropathy in rats. International Immunopharmacology, 163. p. 115260. ISSN 1567-5769

Preview

Accepted Version
Available under License Creative Commons Attribution.
Download (5MB) | Preview

Official URL: https://doi.org/10.1016/j.intimp.2025.115260

Abstract

Diabetic nephropathy (DN) is a kidney complication associated with diabetes that can lead to renal failure. The dipeptidyl peptidase IV inhibitor sitagliptin (SITA) has shown potential therapeutic benefits for DN. This study investigated the effect of SITA on DN, focusing on its modulation of the farnesoid X receptor (FXR) and nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) signaling and its suppressive efficacy on inflammation and oxidative stress. Thirty-two male rats were divided into four groups: control, SITA-treated, diabetic, and SITA-treated diabetic rats. SITA was administered orally for 8 weeks to diabetic rats induced with streptozotocin, after which samples were collected for analysis. The results indicate that SITA effectively reduced hyperglycemia, weight loss, and kidney injury and fibrosis. SITA also decreased oxidative stress, inflammatory markers, and apoptosis, as demonstrated by reductions in kidney malondialdehyde (MDA), myeloperoxidase, nitric oxide (NO), nuclear factor-kappaB (NF-κB), interleukin (IL)-1β, inducible NO synthase (iNOS), tumor necrosis factor (TNF)-α, Bcl-2-associated X protein (Bax), and caspase-3. These protective effects were associated with Kelch-like ECH-associated protein (Keap)-1 inhibition, increased levels of Nrf2 and FXR, and enhanced antioxidant activity as well as Bcl-2 upregulation. In silico analysis showed the binding of SITA with FXR, NF-κB p65, iNOS, Keap-1, caspase-3, and HO-1. In conclusion, SITA mitigates DN by reducing hyperglycemia, inflammation, and oxidative stress, while enhancing antioxidant defenses, FXR and Nrf2/HO-1 signaling.

Item Type:	Article (Article)
Peer-reviewed:	Yes
Date Deposited:	24 Sep 2025 15:13
Publisher:	Elsevier
Additional Information:	This is an author accepted manuscript of an article published in International Immunopharmacology, by Elsevier. This version is deposited with a Creative Commons Attribution 4.0 licence [https://creativecommons.org/licenses/by/4.0/], in accordance with Man Met's Research Publications Policy. The version of record can be found on the publisher's website.
Divisions:	Organisation > Science and Engineering Organisation > Science and Engineering > Department of Life Science
Subject terms:	1115 Pharmacology and Pharmaceutical Sciences, Immunology, 3204 Immunology, 3214 Pharmacology and pharmaceutical sciences
Data Access Statement:	The manuscript and supplementary material contain all data supporting the reported results.
URI:	https://e-space.mmu.ac.uk/id/eprint/641725
DOI:	https://doi.org/10.1016/j.intimp.2025.115260
ISSN	1567-5769
e-ISSN	1878-1705

Impact and Reach

Statistics

DownloadsShow export options

Activity Overview

6 month trend

6Downloads

6 month trend

29Hits

Additional statistics for this dataset are available via IRStats2.

Altmetric

Repository staff only

Edit record